药物洗脱球囊市场增长、规模、份额、趋势、关键参与者分析及 2031 年预测

  • Report Code : TIPRE00003085
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Drug-Eluting Balloon Market Research Report 2021-2031

Buy Now

预计2021年药物洗脱球囊市场规模为76256万美元,2023年为XX万美元,预计到2031年将达到366364万美元;预计到 2031 年,复合年增长率将达到 17.5%。 DCB 疗法的引入可能仍然是药物洗脱球囊市场的一个关键趋势。  

 

药物洗脱球囊市场分析

药物洗脱球囊代表了一种尖端技术,彻底改变了各种慢性疾病的治疗,包括心血管和外周血管疾病。医疗技术的进步简化了血管内阻塞的管理。心血管、外周血管和神经血管疾病等疾病的患病率不断上升,是药物洗脱球囊市场增长的关键驱动力。例如,全球心血管疾病发病率大幅上升。促成因素包括肥胖、体力活动减少、压力水平升高和生活方式的改变,所有这些都导致心血管疾病发生率上升。欧洲心脏病学会已将心房颤动确定为最常见的心律失常形式,占欧洲医疗保健预算的 0.28-2.6%。此外,心房颤动患者面临的中风风险是平均水平的 5 倍,欧洲所有中风事件中,心房颤动占 20-30%。该协会 2016 年的一项研究显示,欧盟约有 760 万 65 岁或以上的人受到房颤的影响。预计到 2060 年,受影响人数将大幅增加,预计将有 1,440 万人受到影响,增幅达 89%。心房颤动的患病率预计也将从 2016 年的 7.8% 上升至 2060 年的 9.5%。此外,Biosense Webster 2019 年题为“心房颤动对亚太地区的影响”的报告显示,亚太地区约有 1600 万人患有心房颤动。患有心房颤动的人数预计到 2050 年将增加到近 7200 万人。这种情况在老年人和中年人群中尤为普遍,他们患此病的风险更高。因此,药物洗脱球囊在心血管疾病的治疗中发挥着至关重要的作用。根据美国疾病控制与预防中心的数据,在美国,每年每 1,000 人中约有 1-2 人受到深静脉血栓 (DVT) 的影响。随着血管疾病发病率的上升,药物洗脱球囊的需求预计在不久的将来将大幅增长。  

 

药物洗脱球囊市场概述

全球药物洗脱球囊市场按地区分为北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。药物洗脱球囊的最大市场由北美地区占据。推动市场增长的关键因素包括血管疾病发病率显着上升、老年人口增加以及产品创新不断增长。然而,由于预测期内严格的审批规定以及程序和产品的高成本,预计市场增长缓慢。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

药物洗脱球囊市场:

药物洗脱球囊市场
  • Drug-Eluting Balloon Market
    年均复合增长率(2023 - 2031)
    17.5%
  • 2021年市场规模
    7.6256亿美元
  • 2031年市场规模
    36.6364亿美元

市场动态

增长动力
  • 血管疾病发病率显着上升
未来的趋势
  • 药物洗脱球囊的使用越来越多,而不是药物洗脱支架
机会
  • 不断增加产品创新、批准和发布以吸引市场

关键人物;主力;重要一员

  • 美敦力公司
  • 贝克顿·迪金森公司
  • 波士顿科学公司
  • 库克医疗
  • 贝朗梅尔松根股份公司
  • 皇家飞利浦公司
  • 光电电路有限公司
  • 泰尔茂株式会社
  • 百多力股份公司
  • Involution 医疗保健列兵。有限公司

区域概况

Drug-Eluting Balloon Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Drug-Eluting Balloon Market产品类别
  • 外周药物洗脱球囊
  • 冠状动脉药物洗脱球囊
  • 其他产品类型
Drug-Eluting Balloon Market最终用户
  • 医院
  • 门诊手术中心
  • 导管实验室和心脏中心
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

药物洗脱球囊市场驱动因素和机遇

 

不断增加产品创新、批准和发布以吸引市场

药物洗脱球囊市场包括成熟的市场领导者和新兴公司。其中领先的参与者包括库克医疗公司、皇家飞利浦公司(隶属于皇家飞利浦公司)、美敦力公司和波士顿科学公司,而许多新兴公司也在这一领域崭露头角。这些公司积极参与各种医疗器械的持续开发,不断改进其产品,以维持和增强其在全球市场的地位。

例如,2024 年 3 月,波士顿科学公司的 AGENT 药物涂层球囊 (DCB) 获得美国食品和药物管理局 (FDA) 批准,用于治疗患有以下疾病的患者的冠状动脉支架内再狭窄 (ISR)冠状动脉疾病。 ISR 涉及由于斑块或疤痕组织的积聚而导致先前已植入支架的血管阻塞或变窄。

2023 年 6 月,Surmodics, Inc. 的 SurVeil 药物涂层球囊 (DCB) 获得美国食品和药物管理局 (FDA) 的批准。该批准允许 SurVeil DCB 在美国境内营销和销售。它设计供医生在进行适当的血管准备后,在经皮腔内血管成形术中使用,以治疗股动脉和腘动脉中长度达 180 毫米的新发或复发病变,参考血管直径范围为 4 毫米至 7 毫米。

老牌公司和新进入者创新产品的推出推动了药物洗脱球囊市场的增长。这主要归因于这些产品为医生治疗心血管疾病、外周动脉疾病(PAD)和肾动脉疾病等提供了更多的治疗选择。  

 

药物洗脱球囊取代药物洗脱支架的使用不断增加——药物洗脱球囊市场的机遇

与药物洗脱支架相比,药物洗脱球囊显示出多种优点。这些球囊是采用期待已久的新型经导管技术开发的,该技术已显示出降低外周动脉疾病高再狭窄率的有希望的因素。 

因此,药物洗脱球囊实现了药物洗脱支架所不具备的各种发展。例如,通过球囊输送药物不需要聚合物或支架来输送药物,并且可以减少血管炎症反应。这些反应还与非常晚期的血栓形成事件直接相关,而药物洗脱支架需要基于聚合物的药物涂层。

药物洗脱球囊的其他优点包括更快地将药物动力学传递到血管,并且内膜在球囊膨胀的 30-60 秒内完成。然而,通过 DES 的药物输送速度缓慢,并且通过控制药物动力学释放来阻止细胞增殖。因此,药物洗脱球囊相对于药物洗脱支架的优势预计将在未来几年增加药物洗脱球囊的采用。  

 

药物洗脱球囊市场报告细分分析

有助于药物洗脱球囊市场分析的关键部分是产品类型和最终用户。

  • 根据产品类型,药物洗脱球囊市场分为冠状动脉药物洗脱球囊、外周药物洗脱球囊和其他产品类型。2023年,外周药物洗脱球囊细分市场占据较大市场份额。
  • 就最终用户而言,市场分为医院、导管实验室和心脏中心、门诊手术中心。 2023 年,医院细分市场将占据市场主导地位。

 

按地域划分的药物洗脱球囊市场份额分析

药物洗脱球囊市场报告的地理范围主要分为五个地区:亚太地区、欧洲、北美、中东和非洲、南美洲和中美洲。  

北美主导了药物洗脱球囊市场。在美国,由于外周动脉疾病 (PAD) 发病率的增加、FDA 批准的增加、医疗器械行业的不断发展等,药物洗脱球囊市场预计将增长。估计市场增长的大部分是由于外周动脉疾病发病率的显着增加。美国不断增长的老年人口预计将增加外周动脉疾病的发病率。克利夫兰诊所报告称,心脏瓣膜疾病影响着美国约 2.5% 的人口,其中包括瓣膜反流和狭窄等疾病。超过 200 万美国人受到心脏瓣膜渗漏的影响。预计亚太地区未来几年将以最高的复合年增长率增长。      

 

药物洗脱球囊市场报告范围

报告属性细节
2021年市场规模7.6256 亿美元
2031 年市场规模36.6364亿美元
全球复合年增长率(2023 - 2031)17.5%
历史数据2021-2022
预测期2023-2031
涵盖的细分市场按产品类型
  • 外周药物洗脱球囊
  • 冠状动脉药物洗脱球囊
  • 其他产品类型
按最终用户
  • 医院
  • 门诊手术中心
  • 导管实验室和心脏中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 美敦力公司
  • 贝克顿·迪金森公司
  • 波士顿科学公司
  • 库克医疗
  • 贝朗梅尔松根股份公司
  • 皇家飞利浦公司
  • 光电电路有限公司
  • 泰尔茂株式会社
  • 百多力股份公司
  • Involution 医疗保健列兵。有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

药物洗脱球囊市场新闻和最新动态

药物洗脱球囊市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是创新、业务扩展和战略市场发展的列表:

  • 2023 年 11 月,OrbusNeich Medical Group Holdings Limited 收购了 Eucatech AG,这是一家总部位于德国的公司,专门从事心血管和血管内治疗微创产品的创建、生产和分销。此次交易后,Eucatech AG 将作为集团的全资子公司运营。 (来源:OrbusNeich 医疗集团控股公司,2023 年)
  • 2022 年 10 月,Cordis 宣布收购 MedAlliance,这是一家位于瑞士、以其创新药物洗脱球囊而闻名的公司。此次收购使 Cordis 能够通过其 SELUTION SLR(持续 Limus 释放)药物洗脱球囊到 2027 年覆盖全球 200 万患者。 (来源:康得思,2022 年)     

 

药物洗脱球囊市场报告范围和交付成果

《药物洗脱球囊市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 药物洗脱球囊市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 药物洗脱球囊市场趋势
  • 详细的 PEST 和 SWOT 分析
  • 药物洗脱球囊市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 药物洗脱球囊市场行业格局和竞争分析,包括市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介  
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..